Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
Authors
Keywords
-
Journal
ACTA NEUROPATHOLOGICA
Volume 124, Issue 3, Pages 411-424
Publisher
Springer Nature
Online
2012-07-05
DOI
10.1007/s00401-012-1009-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
- (2012) Giancarlo Comi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
- (2012) Ulf Schulze-Topphoff et al. PLoS One
- Laquinimod, a once-daily oral drug in development for the treatment of relapsing–remitting multiple sclerosis
- (2012) Wolfgang Brück et al. Expert Review of Clinical Pharmacology
- Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor
- (2011) Jan Thöne et al. AMERICAN JOURNAL OF PATHOLOGY
- IκB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-κB in the central nervous system
- (2011) Jenni Raasch et al. BRAIN
- Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model
- (2011) Hye Jung Kim et al. FASEB JOURNAL
- Insight into the mechanism of laquinimod action
- (2011) W. Brück et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis
- (2010) Christiane Wegner et al. JOURNAL OF NEUROIMMUNOLOGY
- Effects of Fumaric Acids on Cuprizone Induced Central Nervous System De- and Remyelination in the Mouse
- (2010) Darius Moharregh-Khiabani et al. PLoS One
- Statin Therapy Inhibits Remyelination in the Central Nervous System
- (2009) Veronique E. Miron et al. AMERICAN JOURNAL OF PATHOLOGY
- Oral laquinimod therapy in relapsing multiple sclerosis
- (2009) Jana Preiningerova EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Transgenic Inhibition of Astroglial NF- B Improves Functional Outcome in Experimental Autoimmune Encephalomyelitis by Suppressing Chronic Central Nervous System Inflammation
- (2009) R. Brambilla et al. JOURNAL OF IMMUNOLOGY
- Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate
- (2009) V. Skihar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) G Comi et al. LANCET
- Distinct Stages of Myelination Regulated by γ-Secretase and Astrocytes in a Rapidly Myelinating CNS Coculture System
- (2008) Trent A. Watkins et al. NEURON
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started